Welcome to the e-CCO Library!

P800: Five-year prospective follow-up of paediatric IBD patients based on HUPIR (Hungarian paediatric IBD registry)
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.E. Müller1*, HUPIR Group, G. Veres2

Created: Thursday, 21 February 2019, 9:14 AM
P800: Upadacitinib is effective and safe for Crohn's Disease: prospective real-world experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Friedberg, S.(1)*;Choi, D.(1);Hunold, T.(1);Choi, N.K.(1);Garcia, N.M.(1);Picker, E.A.(1);Cohen, N.A.(1);Cohen, R.D.(1);Dalal, S.R.(1);Pekow, J.(1);Sakuraba, A.(1);Cleveland, N.K.(1);Rubin, D.T.(1);
Created: Friday, 14 July 2023, 11:12 AM
P801 Treatment patterns of complex perianal fistula in Crohn’s disease in five European countries: the PREFACE study, a retrospective chart review
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Ferrante1, L. Siproudhis2, G. Poggioli3, M. Reinshagen4, S. Milicevic5, M. Roset6, B. Thun7, N. Bent-Ennakhil8, R. D′Ambrosio8, A. Fernandez-Nistal5, J. Panes9

Created: Thursday, 30 January 2020, 10:12 AM
P801: Maintenance phase effectiveness and persistence after two years in biologic-naïve ulcerative colitis patients treated with vedolizumab or anti-TNF (VEDO-IBD-study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Plachta-Danielzik, S.(1);Bokemeyer, B.(1,2,3)*;Efken, P.(4);Mohl, W.(5);Krause, T.(6);Hoffstadt, M.(7);Ehehalt, R.(8);Trentmann, L.(9);Schweitzer, A.(10);Jessen, P.(11);Franzenburg, S.(1);Hartmann, P.(4);di Giuseppe, R.(1);Schreiber, S.(1,3);
Created: Friday, 14 July 2023, 11:12 AM
P801: Physicians’ knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. S. Macaluso*1, G. Mazzola2, M. Ventimiglia1, P. Alvisi3, S. Renna1, L. Adamoli2, M. Galli4, A. Armuzzi5, S. Ardizzone6, A. Cascio2, M. Cottone1, A. Orlando1

Created: Friday, 22 February 2019, 9:41 AM
P801: Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004–2015
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Lee1, S.Y. Shin2*, J.J. Park2, J.H. Cheon3, T.I. Kim3, H. Park2, W.H. Kim3, A.S. Shin1

Created: Thursday, 21 February 2019, 9:14 AM
P802 Probability of vedolizumab response as defined by clinical decision support tool is associated with lower healthcare utilisation in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Dulai1, Y. Wan2, Z. Huang2, M. Luo2

Created: Thursday, 30 January 2020, 10:12 AM
P802: Perforating Crohn's Disease and pancolitis as risk factors for incident cancer: a prospective multi-centre nested case–control IG-IBD study at 6 years
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Petruzziello1, A. Armuzzi2, M. L. Scribano3, F. Castiglione4, R. D'incà5, M. Daperno6, C. Papi7, M. Vecchi8, W. Fries9, G. Riegler10, P. Alvisi11, F. Mocciaro12, B. Neri13, S. Festa7, A. Testa14, E. Calabrese15, R. Di Mitri16, E. De Crstofaro1, C. Gesuale1, L. Spina17, F. Rogai18, S. Renna19, G. Meucci20, L. Guidi21, A. Rossi15, A. Orlando19, L. Biancone*15

Created: Friday, 22 February 2019, 9:41 AM
P802: Relationships between validated clinical, endoscopic and histological indices in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Walsh, A.(1);Kormilitzin, A.(1);Friedrich, M.(1);Pakpoor, J.(1);HosackMBChB MSc MRCP, T.(1)*;Matini, L.(1);Kantschuster, R.(1);Sharda, A.(1);Dunbar, G.(1);Cheung, V.T.F.(1);Ambrose, T.(1);Brain, A.O.(1);Palmer, R.(1);Satsangi, J.(1);Travis, S.P.L.(1);
Created: Friday, 14 July 2023, 11:12 AM
P802: The experience of chronic disease patients with health care can influence adherence to medication. IEXPAC Project
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Casellas1*, I. Marín-Jiménez2, J. de Toro3, M.J. Galindo4, B. Juliá5, L. Cea-Calvo5, D. Orozco-Beltrán6

Created: Thursday, 21 February 2019, 9:14 AM
P803 The risk of spine and hip fracture in patients with inflammatory bowel diseases: a nationwide population-based study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y.J. Kim1, H.J. Ahn2, S. Noh3, J.C. Park3, J.Y. Kim3, J. Kim3, N.S. Ham3, E.H. Oh3, S.W. Hwang3, D.H. Yang3, B.D. Ye3, J.S. Byeon3, S.J. Myung3, S.K. Yang3, S.H. Park3

Created: Thursday, 30 January 2020, 10:12 AM
P803: A single-centre study on the uptake of cervical cancer screening in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Nwaezeigwe*1, A. Keogh2, L. Egan2

Created: Friday, 22 February 2019, 9:41 AM
P803: Non-immunity against hepatitis B virus in patients with newly diagnosed inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

H.S. Lee1*, S.J. Yeo1, E.S. Kim1, B.I. Jang2, Y.J. Lee3, E.Y. Kim4, C.H. Yang5, H.J. Lee3, Crohn’s and Colitis Association in DaeguGyeongbuk (CCAiD)

Created: Thursday, 21 February 2019, 9:14 AM
P803: Plasma N-glycan biomarkers predict patient Response to Vedolizumab treatment for Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Elgood Hunt, G.(1)*;Adams, A.(2);Senard, T.(1);Gardner, R.(1);Jonge, W.(3);Li Yim, A.(3);Noble, A.(2);Satsangi, J.(2);Joustra, V.(3);D'Haens, G.(3);Spencer, D.(1);
Created: Friday, 14 July 2023, 11:12 AM
P804 Temporal trends and the influence of regional and socioeconomic status on the incidence of inflammatory bowel disease: Using National Health Insurance Service Database in Korea, 2005–2017
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Kim1, J. Lee4, G. Kwak2, Y. Park3, S. Oh1, S. -1, K. Yang5, H. Yoon3, K. Kim1

Created: Thursday, 30 January 2020, 10:12 AM
P804: Development and Validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance (GENIE)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jatkowska, A.(1);White, B.(1);Nichols, B.(1);Svolos, V.(1);Gkikas, K.(1);Hansen, R.(2);Russell, R.K.(3);Gaya, D.(4);Brownson, E.(5);Seenan, J.P.(5);Milling, S.(6);MacDonald, J.(5);Gerasimidis, K.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P804: Prevalence of fybromialgia in IBD patients: a single-centre observational prospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Variola*1, M. Di Ruscio1, A. Geccherle1, A. Marchetta2, I. Tinazzi2

Created: Friday, 22 February 2019, 9:41 AM
P804: Retrospective observational claims data analysis of German statutory health insurance (SHI) patients with Crohn’s disease reveals low prevalence of perianal fistulas (3.4%), but high rates of biologic treatment and inpatient surgical intervention
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Georgiadou1, A. Brandes2, L. Fanter2*, B. Ratsch2, E. Garal-Pantaler1, H. Friedel1

Created: Thursday, 21 February 2019, 9:14 AM
P805 Patients with Crohn’s disease treated with ustekinumab vs. vedolizumab in real-world settings
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Chiorean Physician1, J. Jiang2, N. Candela2, G. Chen3, H. Romdhani4, D. Latremouille-Viau4, S. Shi4, R. Bungay4, T. Fan2

Created: Thursday, 30 January 2020, 10:12 AM
P805: Adherence to Mediterranean diet is associated with decreased faecal calprotectin in patients after pouch surgery
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Godny1,2*, T. Pfeffer-Gik1,2, I. Goren1,2, H. Tulchinsky3, I. Dotan1,2

Created: Thursday, 21 February 2019, 9:14 AM